Top compounds associated with response to CLINT1


Feature Type Standardized
Nominal ANOVA
mRNA lenalidomide FIMM pan-cancer AAC -0.36 0.04
mRNA lapatinib gCSI pan-cancer AAC 0.11 0.04
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.073 0.04
mRNA BRD-K66532283 CTRPv2 pan-cancer AAC -0.068 0.04
mRNA Vandetanib CCLE pan-cancer AAC 0.096 0.04
mRNA Lisitinib GDSC1000 pan-cancer AAC 0.068 0.04
mRNA PD-0325901 gCSI pan-cancer AAC 0.1 0.04
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.067 0.05
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.05
mRNA PHA-665752 CCLE pan-cancer AAC 0.094 0.05
Download CSV